MERTK is a host factor that promotes classical swine fever virus entry and antagonizes innate immune response in

Guanglai Zheng1, Lian-Feng Li1, Yuexiu Zhang1

  • 1State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, People's Republic of China.

Insights

This study identifies MERTK as a crucial host factor for Classical swine fever virus (CSFV) entry and replication. MERTK facilitates CSFV infection by interacting with the virus and suppressing innate immune responses.

Area of Science:

  • Virology
  • Immunology
  • Cell Biology

Background:

  • Classical swine fever virus (CSFV) poses a significant threat to swine populations globally.
  • The host factors governing CSFV entry and replication are not fully understood, hindering effective control strategies.

Purpose of the Study:

  • To identify host membrane proteins essential for CSFV infection.
  • To elucidate the mechanism by which MERTK influences CSFV pathogenesis.

Main Methods:

  • Transcriptomic data analysis to identify candidate host factors.
  • RNA interference screening using a CSFV-luciferase reporter system.
  • In vitro assays using anti-MERTK antibodies and soluble MERTK ectodomain to assess viral inhibition.
  • Co-immunoprecipitation to confirm MERTK-CSFV E2 protein interaction.
  • Analysis of Interferon-beta (IFN-β) mRNA expression.

Main Results:

  • Twelve novel candidate host proteins were identified, with MERTK showing significant impact on CSFV replication.
  • MERTK was confirmed as a CSFV entry factor, interacting with the viral E2 protein.
  • Anti-MERTK antibodies and soluble MERTK ectodomain dose-dependently reduced CSFV infection in PK-15 cells.
  • MERTK was found to downregulate IFN-β mRNA expression, thereby promoting CSFV infection.
  • Soluble MERTK ectodomain also inhibited infection by bovine viral diarrhea virus (BVDV), another pestivirus.

Conclusions:

  • MERTK is a critical host factor for CSFV entry and replication.
  • MERTK actively dampens innate immune responses, specifically IFN-β production, to facilitate viral infection.
  • MERTK represents a potential therapeutic target for CSFV and possibly other pestivirus infections.